101 related articles for article (PubMed ID: 9353851)
1. Diabetes-induced protection from cisplatin nephrotoxicity is associated with impairment of energy-dependent uptake by renal cortex slices.
Sarangarajan R; Cacini W
Pharmacol Toxicol; 1997 Oct; 81(4):197-8. PubMed ID: 9353851
[No Abstract] [Full Text] [Related]
2. Reduced renal accumulation and toxicity of cisplatin in experimental galactosemia.
Cacini W; Harden EA; Skau KA
Proc Soc Exp Biol Med; 1993 Jul; 203(3):348-53. PubMed ID: 8516346
[TBL] [Abstract][Full Text] [Related]
3. Influence of streptozotocin (STZ)-induced diabetes, dextrose diuresis and acetone on cisplatin nephrotoxicity in Fischer 344 (F344) rats.
Scott LA; Madan E; Valentovic MA
Toxicology; 1990; 60(1-2):109-25. PubMed ID: 2107603
[TBL] [Abstract][Full Text] [Related]
4. Role of P-glycoprotein in chronic cyclosporine nephrotoxicity and its relationship to intrarenal angiotensin II deposits.
Del Moral RG; Olmo A; Osuna A; Aguilar M; Carvia R; Becerra P; Arrebola F; Guillén M; Reguero ME; Asensio C; O'Valle F
Transplant Proc; 1998 Aug; 30(5):2014-6. PubMed ID: 9723372
[No Abstract] [Full Text] [Related]
5. Modification of cisplatin-induced renal p-aminohippurate uptake alteration and lipid peroxidation by thiols, Ginkgo biloba extract, deferoxamine and torbafylline.
Inselmann G; Blöhmer A; Kottny W; Nellessen U; Hänel H; Heidemann HT
Nephron; 1995; 70(4):425-9. PubMed ID: 7477647
[TBL] [Abstract][Full Text] [Related]
6. The effect of methylprednisolone on cisplatin-induced nephrotoxicity in rat renal cortical slices.
Uozumi J; Koikawa Y; Yasumasu T; Ueda T; Kumazawa J
Res Exp Med (Berl); 1995; 195(4):231-5. PubMed ID: 8525073
[TBL] [Abstract][Full Text] [Related]
7. Effect of platinum coordination complex (PtCx) on citrate uptake by rat renal brush border membrane vesicles (BBMV): cisplatin-intoxicated rats.
Sato K; Kusaka Y; Chiba Y; Okada K
Ind Health; 2001 Oct; 39(4):317-21. PubMed ID: 11758994
[TBL] [Abstract][Full Text] [Related]
8. Renal metallothionein and platinum levels in diabetic and nondiabetic rats injected with cisplatin.
Cacini W; Singh Y
Proc Soc Exp Biol Med; 1991 Jul; 197(3):285-9. PubMed ID: 2068122
[TBL] [Abstract][Full Text] [Related]
9. Association between increased atrial natriuretic peptide and reduced cisplatin nephrotoxicity in rats.
Ormond PM; Basinger MA; Jones MM; Hande KR
J Pharmacol Exp Ther; 1992 Jul; 262(1):246-51. PubMed ID: 1385629
[TBL] [Abstract][Full Text] [Related]
10. Kidney slices of human and rat to characterize cisplatin-induced injury on cellular pathways and morphology.
Vickers AE; Rose K; Fisher R; Saulnier M; Sahota P; Bentley P
Toxicol Pathol; 2004; 32(5):577-90. PubMed ID: 15603542
[TBL] [Abstract][Full Text] [Related]
11. Amelioration of cisplatin toxicity in rat renal cortical slices by dithiothreitol in vitro.
Zhang JG; Zhong LF; Zhang M; Ma XL; Xia YX; Lindup WE
Hum Exp Toxicol; 1994 Feb; 13(2):89-93. PubMed ID: 7908816
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin-induced changes in adenine nucleotides in rat kidney slices: amelioration by tiopronin and procaine.
Zhang JG; Lindup WE
J Pharm Pharmacol; 1997 Nov; 49(11):1136-40. PubMed ID: 9401952
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin nephrotoxicity is mediated by gamma glutamyltranspeptidase, not via a C-S lyase governed biotransformation pathway.
Wainford RD; Weaver RJ; Stewart KN; Brown P; Hawksworth GM
Toxicology; 2008 Jul; 249(2-3):184-93. PubMed ID: 18583013
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol attenuates cisplatin-induced nephrotoxicity in rats.
Do Amaral CL; Francescato HD; Coimbra TM; Costa RS; Darin JD; Antunes LM; Bianchi Mde L
Arch Toxicol; 2008 Jun; 82(6):363-70. PubMed ID: 18026934
[TBL] [Abstract][Full Text] [Related]
15. Absence of Sirt3 aggravates cisplatin nephrotoxicity via enhanced renal tubular apoptosis and inflammation.
Kim D; Park W; Lee S; Kim W; Park SK; Kang KP
Mol Med Rep; 2018 Oct; 18(4):3665-3672. PubMed ID: 30106119
[TBL] [Abstract][Full Text] [Related]
16. Stimulation of gluconeogenesis by adenosine in renal cortical tubule fragments from fed rats.
Rodin DA; Rodin RA; Saggerson ED
Biochem Pharmacol; 1980 Mar; 29(5):828-9. PubMed ID: 20227964
[No Abstract] [Full Text] [Related]
17. Elemental bioimaging in kidney by LA-ICP-MS as a tool to study nephrotoxicity and renal protective strategies in cisplatin therapies.
Moreno-Gordaliza E; Giesen C; Lázaro A; Esteban-Fernández D; Humanes B; Cañas B; Panne U; Tejedor A; Jakubowski N; Gómez-Gómez MM
Anal Chem; 2011 Oct; 83(20):7933-40. PubMed ID: 21913725
[TBL] [Abstract][Full Text] [Related]
18. Phlda3, a urine-detectable protein, causes p53 accumulation in renal tubular cells injured by cisplatin.
Lee CG; Kang YJ; Kim HS; Moon A; Kim SG
Cell Biol Toxicol; 2015 Apr; 31(2):121-30. PubMed ID: 25809501
[TBL] [Abstract][Full Text] [Related]
19. The renal fractional clearance of platinum antitumour compounds in relation to nephrotoxicity.
Daley-Yates PT; McBrien DC
Biochem Pharmacol; 1985 May; 34(9):1423-8. PubMed ID: 4039567
[TBL] [Abstract][Full Text] [Related]
20. Functional impairment of renal organic cation transport in experimental diabetes.
Grover B; Auberger C; Sarangarajan R; Cacini W
Pharmacol Toxicol; 2002 Apr; 90(4):181-6. PubMed ID: 12076311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
